Valuation
- Market cap
- 191,656,000
- Revenue TTM
- $40,000
- Net income TTM
- $-10,330,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -25,825.00%
- Debt to equity
- 0.00
Trading
- Volume
- 3,137,700
- Avg volume
- 1,189,572
- Day's range
- $4.36 – $6.12
- Shares out
- 31,419,000
- Stochastic %K
- 99%
- Beta
- 1.82
- Analysts
- Moderate Buy
- Price target
- $10.00
Company profile
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, p...
Show more
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 203 409 5444
- Website
- https://www.biosig.com
- Address
- 12424 Wilshire Blvd, Suite 745, Los Angeles, United States
Latest news
No headlines yet.
